Cargando…

In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2

BACKGROUND: The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provoked researchers to propose multiple antiviral strategies to improve patients’ outcomes. Studies provide evidence that cyclosporine A (CsA) decreases SARS-CoV-2 replication in vitro and decreases mortality rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurie, Kyle, Holcomb, David, Kames, Jacob, Komar, Anton A, DiCuccio, Michael, Ibla, Juan C, Kimchi-Sarfaty, Chava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083350/ https://www.ncbi.nlm.nih.gov/pubmed/34109257 http://dx.doi.org/10.1093/ofid/ofab189

Ejemplares similares

Gene variants of coagulation related proteins that interact with SARS-CoV-2
por: Holcomb, David, et al.
Publicado: (2021)

Protocol to identify host-viral protein interactions between coagulation-related proteins and their genetic variants with SARS-CoV-2 proteins
por: Holcomb, David D., et al.
Publicado: (2022)

Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design
por: Kames, Jacob, et al.
Publicado: (2020)

Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design
por: Kames, Jacob, et al.
Publicado: (2020)

Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage
por: Meyer, Douglas, et al.
Publicado: (2021)

Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies
por: Fumagalli, Sarah E., et al.
Publicado: (2023)

Ribosome profiling of HEK293T cells overexpressing codon optimized coagulation factor IX
por: Alexaki, Aikaterini, et al.
Publicado: (2020)

Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance
por: Jankowska, Katarzyna I., et al.
Publicado: (2022)

A Single Synonymous Variant (c.354G>A [p.P118P]) in ADAMTS13 Confers Enhanced Specific Activity
por: Hunt, Ryan, et al.
Publicado: (2019)

Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies
por: Alexaki, Aikaterini, et al.
Publicado: (2019)

In silico methods for predicting functional synonymous variants
por: Lin, Brian C., et al.
Publicado: (2023)

Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants
por: Katneni, Upendra K., et al.
Publicado: (2019)

Cyclophilins and cyclophilin inhibitors in nidovirus replication
por: de Wilde, Adriaan H., et al.
Publicado: (2018)

Sensitive measurement of single-nucleotide polymorphism-induced changes of RNA conformation: application to disease studies
por: Salari, Raheleh, et al.
Publicado: (2013)

Structural, functional, and immunogenicity implications of F9 gene recoding
por: Katneni, Upendra K., et al.
Publicado: (2022)

In silico analysis of the cyclophilin repertoire of apicomplexan parasites
por: Krücken, Jürgen, et al.
Publicado: (2009)

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)
por: Softic, Laurent, et al.
Publicado: (2020)

Collection and curation of prokaryotic genome assemblies from type strains at NCBI
por: Kannan, Sivakumar, et al.
Publicado: (2023)

Using average nucleotide identity to improve taxonomic assignments in prokaryotic genomes at the NCBI
por: Ciufo, Stacy, et al.
Publicado: (2018)

Cyclophilin inhibitors as antiviral agents
por: Peel, Michael, et al.
Publicado: (2013)

Non‐Immunosuppressive Cyclophilin Inhibitors
por: Schiene‐Fischer, Cordelia, et al.
Publicado: (2022)

The Cyclophilin-Dependent Calcineurin Inhibitor Voclosporin Inhibits SARS-CoV-2 Replication in Cell Culture
por: Ogando, Natacha S., et al.
Publicado: (2022)

Characterization of Coding Synonymous and Non-Synonymous Variants in ADAMTS13 Using Ex Vivo and In Silico Approaches
por: Edwards, Nathan C., et al.
Publicado: (2012)

Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV‐2
por: Sekhon, Simranjeet Singh, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen
por: Madsen, Johannes R, et al.
Publicado: (2021)

Suppression of Coronavirus Replication by Cyclophilin Inhibitors
por: Tanaka, Yoshikazu, et al.
Publicado: (2013)

The Genome Assembly Archive: A New Public Resource
por: Salzberg, Steven L, et al.
Publicado: (2004)

Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic
por: Uhteg, Katharine, et al.
Publicado: (2021)

The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
por: Pfefferle, Susanne, et al.
Publicado: (2011)

The Yield and Consistency of the Detection of SARS-CoV-2 in Multiple Respiratory Specimens
por: Zhang, Haixia, et al.
Publicado: (2020)

The Antibody Response to SARS-CoV-2 Infection
por: Hueston, Linda, et al.
Publicado: (2020)

Correlation of SARS-CoV-2 Nasopharyngeal CT Values With Viremia and Mortality in Adults Hospitalized With COVID-19
por: Hagman, Karl, et al.
Publicado: (2022)

Pooled SARS-CoV-2 antigen tests in asymptomatic children and their caregivers: Screening for SARS-CoV-2 in a pediatric emergency department
por: Reichert, Friedrich, et al.
Publicado: (2021)

An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection
por: Scher, Ann I, et al.
Publicado: (2022)

The cyclophilins
por: Wang, Ping, et al.
Publicado: (2005)

Cyclophilin
Publicado: (2011)

Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2
por: Grima, Alicia A, et al.
Publicado: (2022)

Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
por: Ekström, Nina, et al.
Publicado: (2022)

Cyclophilin Inhibitors as a Novel HCV Therapy
por: Tang, Hengli
Publicado: (2010)

The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
por: Foster, R.T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p088vvnuf27q8jrp2nvk4q0919